2009
DOI: 10.1016/j.bbcan.2008.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Protein phosphatase 2A regulatory subunits and cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

9
567
0
6

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 394 publications
(583 citation statements)
references
References 255 publications
9
567
0
6
Order By: Relevance
“…These biological functions are believed to be mediated by the interaction between ST and PP2A (reviewed in Arroyo and Hahn, 2005;Eichhorn et al, 2009). The alteration of the phosphorylation status of signaling molecules has been demonstrated to be the primary action of the ST antigen in cell transformation (Janssens and Goris, 2001; Moreno Sablina and Hahn, 2008).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These biological functions are believed to be mediated by the interaction between ST and PP2A (reviewed in Arroyo and Hahn, 2005;Eichhorn et al, 2009). The alteration of the phosphorylation status of signaling molecules has been demonstrated to be the primary action of the ST antigen in cell transformation (Janssens and Goris, 2001; Moreno Sablina and Hahn, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…To date, the functional loss of PP2A B56g is believed to be the key factor in SV40 ST-induced tumorigenesis (reviewed in Eichhorn et al, 2009). PP2A B56g subunit appears to be a negative upstream regulator controlling miR-27a expression.…”
Section: Discussionmentioning
confidence: 99%
“…Although mutation at the N-terminus of β-catenin has been found in some tumors, mutations at these sites have not been found in Jurkat cells (20). NCTD has been reported to inhibit protein phosphatase 2A (PP2A) activity and PP2A has been found to positively control Wnt/β-catenin signaling upon Wnt stimulation (31,32). In this context, inhibition of PP2A will promote β-catenin phosphorylation and degradation.…”
Section: Discussionmentioning
confidence: 99%
“…Phosphatidylinositol 3-kinase (PI3K)/Akt, mitogen-activated protein kinase, c-Myc, and other cancer signaling pathways that impact cellular processes, including cell cycle progression and cellular tumorigenesis are regulated by specific PP2A isoforms (9). Aberrant expression and mutations in PP2A subunits have been implicated in human cancers (8,(10)(11)(12)(13)(14)(15)(16). …”
mentioning
confidence: 99%
“…This core heterodimer can be purified, but the PP2A holoenzyme generally contains a third, regulatory B subunit that provides substrate specificity and subcellular localization (3)(4)(5)(6)(7). Among the many combinatorial possibilities, there are two C catalytic subunits, at least two 〈 scaffolding subunits, and multiple B substrate recognition subunits (8), which allow for potentially hundreds of different phosphatase specificities and activities. Phosphatidylinositol 3-kinase (PI3K)/Akt, mitogen-activated protein kinase, c-Myc, and other cancer signaling pathways that impact cellular processes, including cell cycle progression and cellular tumorigenesis are regulated by specific PP2A isoforms (9).…”
mentioning
confidence: 99%